ArticleDiscover oncology2026

Integrative in silico transcriptomic and pharmacogenomic analysis of CD276 as a candidate prognostic biomarker and therapeutic target in bladder cancer.

Faruk Recep Özalp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.